Head of Research, Krungthai XSpring

Waraporn Wiboonkanarak

Head of Research

A full service Thai brokerage

Krungthai XSpring

Krungthai XSpring is a full service broker. The company provides a wide range of investment services such as Securities Brokerage, Derivative Agent Business, Securities Borrowing and Lending, Securities Trading, Underwriting, Financial Advisory, Wealth Advisory, Private Fund Management and International Markets Securities Trading. 

In terms of credibility, Fitch Ratings has assigned Krunghtai XSpring a long-term rating of AA- and a national short-term rating of F1+ with stable outlook.

Thematic (Sector/Industry)

<ul><li>Vaccine stocks (NVAX, BNTX, PFE, MRNA, PCVX) had a good week, as the FDA provided new regulatory policy for COVID-19 vaccines.</li><li>While more restrictive and unconventionally delivered in a NEJM op-ed, the publication reduced uncertainty for vaccine makers and gave full support for the measles vaccine by FDA heads.</li><li>Biopharma shrugged off MFN pricing targets, as implementation remained unclear. </li></ul>

Vaccine stocks (NVAX, BNTX, PFE, MRNA, PCVX) had a good week, as the FDA provided new regulatory policy for COVID-19 vaccines.While more restrictive and unconventionally delivered in a NEJM op-ed, the publication reduced uncertainty for vaccine makers and gave full support for the measles vaccine by FDA heads.Biopharma shrugged off MFN pricing targets, as implementation remained unclear. 

Biopharma Week in Review - FDA Provides Some Certainty for Vaccines; ASCO Abstracts Snippets

Equity Bottom-Up

<ul><li>Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points and 1,454 points (10-day EMA).</li><li>Thailand's economy is expected to continue improving YoY in 4Q24E owing to the low base and the government's economic stimulus measures.</li><li>Therefore, we maintain our <b>Trading Buy</b> recommendation if the SET Index moves within the range of 1,393-1,455 points.</li></ul>

Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points and 1,454 points (10-day EMA).Thailand's economy is expected to continue improving YoY in 4Q24E owing to the low base and the government's economic stimulus measures.Therefore, we maintain our Trading Buy recommendation if the SET Index moves within the range of 1,393-1,455 points.

United States

Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Moderna (MRNA US)

Biopharma Week in Review - FDA Provides Some Certainty for Vaccines; ASCO Abstracts Snippets

Vaccine stocks (NVAX, BNTX, PFE, MRNA, PCVX) had a good week, as the FDA provided new regulatory policy for COVID-19 vaccines.

Krungthai XSpring

TH 3Q24 GDP Growth & Weekly Strategy

Technically, the SET Index is expected to move in a sideways-down trend, with the support at 1,432/1,424 points and the resistance at 1,447 points...

Krungthai XSpring

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)